Supporting oncology professionals through education

The content on this site is intended for healthcare professionals only

What should be the HPV vaccine strategy for India?

Choosing Wisely: Value added cancer care for India

15 - 16 Oct 2019

Published: 7 Nov 2019

Views: 1732

Rating:

Save

Dr Rengaswamy Sankaranarayanan - WHO-IARC, Lyon, France

Dr Rengaswamy Sankaranarayanan presents a talk on 'What should be the HPV vaccine strategy for India?' at the Choosing wisely: Value Added Cancer Care for India event in New Delhi.

Related Videos

The genomics of cancer in Africa

Prof Solomon Rotimi - Covenant University, Ota, Nigeria

The genomics of cancer in Africa ( Prof Solomon Rotimi - Covenant University, Ota, Nigeria )

Gender inequity in ovarian cancer research in resource limited settings

Dr Khalid El Bairi - Mohamed First University, Oujda, Morocco

Gender inequity in ovarian cancer research in resource limited settings ( Dr Khalid El Bairi - Mohamed First University, Oujda, Morocco )

Synthetic biology and precision medicine in blood and gynaecological cancers

Dr Mutsa Takundwa - Council for Scientific and Industrial Research, Pretoria...

Synthetic biology and precision medicine in blood and gynaecological cancers ( Dr Mutsa Takundwa - Council for Scientific and Industrial Research, Pretoria, South Africa )

OncoAlert Round Up for September 15-21, 2023

Dr Gil Morgan - Executive Director, OncoAlert

OncoAlert Round Up for September 15-21, 2023 ( Dr Gil Morgan - Executive Director, OncoAlert )

TARGeted IORT INTRABEAM is a useful treatment option for early stage breast...

Dr Elena Sperk - Universitätsmedizin Mannheim, Mannheim, German

TARGeted IORT INTRABEAM is a useful treatment option for early stage breast cancer ( Dr Elena Sperk - Universitätsmedizin Mannheim, Mannheim, German )

Advancing breast cancer diagnosis in the developing world

Dr Hans Junkermann, Prof Dr.Erkin Arıbal and Dr Richard Rainsbury

Advancing breast cancer diagnosis in the developing world ( Dr Hans Junkermann, Prof Dr.Erkin Arıbal and Dr Richard Rainsbury )

Redefining cancer research priorities in the emerging context of the COVID-19...

Prof Richard Sullivan - King's College London, London, UK

Redefining cancer research priorities in the emerging context of the COVID-19 pandemic ( Prof Richard Sullivan - King's College London, London, UK )

Global obstacles to lung cancer screening: Report

Professor Rudolf Huber - The Hospital of the University of Munich, Munich...

Global obstacles to lung cancer screening: Report ( Professor Rudolf Huber - The Hospital of the University of Munich, Munich, Germany )

IASLC Early Detection and Screening Committee: Global obstacles to lung cancer...

Dr Milena Cavic - Institute for Oncology and Radiology of Serbia, Belgrade...

IASLC Early Detection and Screening Committee: Global obstacles to lung cancer screening ( Dr Milena Cavic - Institute for Oncology and Radiology of Serbia, Belgrade, Serbia )

More from ecancer